Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
There has been considerable recent press coverage around the cosmetic industry and standards of practice. For nurses working in the industry, this has focused particularly on their ability and methods of obtaining prescription only medications, such as botulinum toxin for chemical denervation. Any nurse or midwife administering or supplying injectable cosmetic medicinal products must follow the appropriate regulatory standards for practice. Updated guidance from the General Medical Council (2012) have made clear that remote prescribing and directions to administer should only be used in exceptional circumstances, and not as a routine means to administer injectable cosmetic medicinal products. These changes have lead many nurses working in the aesthetics industry to undertake the V300 non-medical prescribing (NMP) course. The NMP course is regulated by the Nursing and Midwifery Council and nurses wishing to undertake the course must demonstrate they meet the eligibility criteria, and that they have appropriate governance procedures in place to protect patient safety.
Journal of Aesthetic Nursing – Mark Allen Group
Published: Mar 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.